Loading...
BVMF
PFRM3
Market cap194mUSD
Dec 05, Last price  
8.65BRL
1D
-6.69%
1Q
8.13%
Jan 2017
9.36%
IPO
-62.34%
Name

Profarma Distribuidora de Produtos Farmaceuticos SA

Chart & Performance

D1W1MN
BVMF:PFRM3 chart
P/E
9.26
P/S
0.10
EPS
0.93
Div Yield, %
3.12%
Shrs. gr., 5y
Rev. gr., 5y
16.16%
Revenues
10.15b
+17.22%
1,519,577,0001,728,608,0002,268,874,0002,535,516,0002,578,291,0002,626,119,0003,317,048,0003,383,636,0003,470,310,0003,449,124,0003,465,143,0004,084,669,0004,100,711,0004,271,127,0004,801,292,0005,481,341,0006,413,199,0007,816,218,0008,661,744,00010,153,623,000
Net income
115m
+62.76%
16,285,000-3,552,00047,032,00031,640,00053,152,00034,382,00029,657,00040,586,00020,353,000-52,117,000-21,182,000-48,963,000-112,720,000-9,734,00011,978,00052,334,00078,192,00080,874,00070,397,000114,579,000
CFO
497m
+90.53%
-15,631,000-98,496,000-162,820,00011,027,00080,249,00044,404,00029,876,0008,934,000-90,119,00058,866,00059,265,000-107,293,000-51,826,000-55,845,000126,923,00039,344,000107,576,000126,322,000260,899,000497,088,000
Dividend
Jan 02, 20260.31808 BRL/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.
IPO date
Oct 26, 2006
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT